Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124790132 | 12479013 | 2 | F | 20160810 | 20160620 | 20160811 | EXP | NO-ROCHE-1778075 | ROCHE | 0.00 | F | Y | 0.00000 | 20160811 | MD | NO | NO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124790132 | 12479013 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | SOLUTION FOR INFUSION | |||||||||
| 124790132 | 12479013 | 2 | SS | MABTHERA | RITUXIMAB | 1 | U | 103705 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124790132 | 12479013 | 1 | Anti-neutrophil cytoplasmic antibody positive vasculitis |
| 124790132 | 12479013 | 2 | Granulomatosis with polyangiitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124790132 | 12479013 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124790132 | 12479013 | Blood immunoglobulin G decreased | |
| 124790132 | 12479013 | Infection | |
| 124790132 | 12479013 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |